Alerts Sign-up
FedEx has expanded its Life Sciences Center in Gimpo, South Korea, enhancing its service capabilities for the healthcare industry across the Asia-Pacific region. This expansion is part of FedEx's response to the growing demand for a robust logistics network with advanced features to support the rapidly expanding healthcare sector in the region.
The South Korean facility now covers 2,288 square meters, nearly three times its previous size. It includes five temperature-controlled areas ranging from -150°C to +25°C, monitored around the clock to meet pharmaceutical cold chain transportation requirements. The center is certified under Korea Good Supply Practice (KGSP) standards and complies with quality and regulatory requirements specific to the healthcare industry. It also offers facilities for both domestic and international transportation needs.
With this expansion, FedEx aims to enhance its expertise in life sciences logistics, ensuring seamless and reliable transport of healthcare-related cargo such as investigational medicinal products (IMP), biological samples, and biopharmaceuticals. This allows FedEx customers involved in pharmaceuticals and clinical trials to focus on patient care.
